|
1
|
El-Kady NM, Esmat G, Mahmoud EH, Darweesh
SK, Mahmoud SH and Elagawy WA: Hypertonic saline-enhanced
radiofrequency versus chemoembolization sequential radiofrequency
in the treatment of large hepatocellular carcinoma. Eur J
Gastroenterol Hepatol. 25:628–633. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fernandez-Banet J, Lee NP, Chan KT, Gao H,
Liu X, Sung WK, Tan W, Fan ST, Poon RT, Li S, et al: Decoding
complex patterns of genomic rearrangement in hepatocellular
carcinoma. Genomics. 103:189–203. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sarwar S, Khan AA and Tarique S: Validity
of alpha fetoprotein for diagnosis of hepatocellular carcinoma in
cirrhosis. J Coll Physicians Surg Pak. 24:18–22. 2014.PubMed/NCBI
|
|
4
|
Jiang F, Wang X, Liu Q, Shen J, Li Z, Li Y
and Zhang J: Inhibition of TGF-β/SMAD3/NF-κB signaling by
microRNA-491 is involved in arsenic trioxide-induced
anti-angiogenesis in hepatocellular carcinoma cells. Toxicol Lett.
231:55–61. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lou XL, Deng J, Deng H, Ting Y, Zhou L,
Liu YH, Hu JP, Huang XF and Qi XQ: Aspirin inhibit platelet-induced
epithelial-to-mesenchymal transition of circulating tumor cells
(Review). Biomed Rep. 2:331–334. 2014.PubMed/NCBI
|
|
6
|
Yang J, Zheng J, Wu L, Shi M, Zhang H,
Wang X, Xia N, Wang D, Liu X, Yao L, et al: NDRG2 ameliorates
hepatic fibrosis by inhibiting the TGF-β1/Smad pathway and altering
the MMP2/TIMP2 ratio in rats. PLoS One. 6:e277102011. View Article : Google Scholar
|
|
7
|
Tijsen AJ, van der Made I, van den
Hoogenhof MM, Wijnen WJ, van Deel ED, de Groot NE, Alekseev S,
Fluiter K, Schroen B, Goumans MJ, et al: The microRNA-15 family
inhibits the TGFβ-pathway in the heart. Cardiovasc Res. 104:61–71.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gal A, Sjöblom T, Fedorova L, Imreh S,
Beug H and Moustakas A: Sustained TGF beta exposure suppresses Smad
and non-Smad signalling in mammary epithelial cells, leading to EMT
and inhibition of growth arrest and apoptosis. Oncogene.
27:1218–1230. 2008. View Article : Google Scholar
|
|
9
|
Chegini N, Luo X, Ding L and Ripley D: The
expression of Smads and transforming growth factor beta receptors
in leiomyoma and myometrium and the effect of gonadotropin
releasing hormone analogue therapy. Mol Cell Endocrinol. 209:9–16.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jeong MH, Kim SJ, Kang H, Park KW, Park
WJ, Yang SY and Yang DK: Cucurbitacin I attenuates cardiomyocyte
hypertrophy via inhibition of connective tissue growth factor
(CCN2) and TGF-β/Smads signalings. PLoS One. 10:e01362362015.
View Article : Google Scholar
|
|
11
|
Choi K, Lee K, Ryu SW, Im M, Kook KH and
Choi C: Pirfenidone inhibits transforming growth factor-β1-induced
fibrogenesis by blocking nuclear translocation of Smads in human
retinal pigment epithelial cell line ARPE-19. Mol Vis.
18:1010–1020. 2012.
|
|
12
|
Zheng F, Lu W, Wu F, Li H, Hu X and Zhang
F: Recombinant decorin ameliorates the pulmonary structure
alterations by downregulating transforming growth
factor-beta1/SMADS signaling in the diabetic rats. Endocr Res.
35:35–49. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang WL, Zhang JH, Wu XZ, Yan T and Lv W:
miR-15b promotes epithelial-mesenchymal transition by inhibiting
SMURF2 in pancreatic cancer. Int J Oncol. 47:1043–1053.
2015.PubMed/NCBI
|
|
14
|
Li CL, Chang L, Guo L, Zhao D, Liu HB,
Wang QS, Zhang P, Du WZ, Liu X, Zhang HT, et al: β-elemene induces
caspase-dependent apoptosis in human glioma cells in vitro through
the upregulation of Bax and Fas/FasL and downregulation of Bcl-2.
Asian Pac J Cancer Prev. 15:10407–10412. 2014. View Article : Google Scholar
|
|
15
|
Reed JC: Proapoptotic multidomain
Bcl-2/Bax-family proteins: Mechanisms, physiological roles, and
therapeutic opportunities. Cell Death Differ. 13:1378–1386. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cory S and Adams JM: Killing cancer cells
by flipping the Bcl-2/Bax switch. Cancer Cell. 8:5–6. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu J, Yang L, Zhang J, Zhang J, Chen Y,
Li K, Li Y, Li Y, Yao L and Guo G: Knock-down of NDRG2 sensitizes
cervical cancer Hela cells to cisplatin through suppressing Bcl-2
expression. BMC Cancer. 12:3702012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ryoo HD and Bergmann A: The role of
apoptosis-induced proliferation for regeneration and cancer. Cold
Spring Harb Perspect Biol. 4:a0087972012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen H, Yang X, Feng Z, Tang R, Ren F, Wei
K and Chen G: Prognostic value of caspase-3 expression in cancers
of digestive tract: A meta-analysis and systematic review. Int J
Clin Exp Med. 8:10225–10234. 2015.PubMed/NCBI
|
